Impax Labs (IPXL) announced a merger agreement with private company Amneal to diversify revenue streams and increase negotiating leverage with group purchasing organizations (“GPOs”). Although the stock has slowly drifted from …
NEW YORK, Oct. 24, 2017 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Impax Laboratories, Inc. ("IPXL ... weisslaw-llp-investigates-impax
NASDAQ: IPXL) announced that they have entered into a business combination in an all-stock transaction. As a result of the transaction, Amneal Holdings members will own approximately 75% and Impax Laboratories Inc (NASDAQ:IPXL) …
SBWire4mon
In March 2018, two of the seven analysts covering Depomed have given the stock a “buy” rating. By comparison, of the 22 analysts covering Merck (MRK) in March 2018, six analysts have given the stock a “strong buy” rating, and seven …